Compared with serum anti-GAD65 antibodies, the CSF antibodies of patients with SPS exhibit a 10-fold higher binding avidity, indicating intrathecal synthesis by clonally restricted GAD65-specific B cells driven by local antigens within the confines of the BBB (4, 10). The gene discussed is GAD2; the disease is stiff-person syndrome.